Serologic Extracellular Matrix Remodeling Markers Are Related to Fibrosis Stage and Prognosis in a Phase 2b Trial of Simtuzumab in Patients with Primary Sclerosing Cholangitis.
Hepatology Communications（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要